Beware of the “Bronchocele,” Particularly in Patients with a History or Risk Factors for a Mucinous Carcinoma: A Response to the Article “Resection of.

Slides:

Advertisements

Similar presentations

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Advertisements

Evaluation of 18F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment Tjeerd S. Aukema, MD, Renato.

Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.

Next Generation Sequencing Uncovers Potential Genetic Driver Mutations of Malignant Pulmonary Granular Cell Tumor Song Xu, Qingchun Zhao, Sen Wei, Yi.

Gingival Metastasis as First Sign of Multiorgan Dissemination of Epithelioid Malignant Mesothelioma Andrea Billè, Marco Platania, Giuseppe Pelosi, Barbara.

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy Shankar Siva, MBBS, FRANZCR, Brent Chesson, BAppSc.

Unilateral Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Multiple Carcinoids Treated with Surgical Resection Sheeba Irshad, Emma McLean,

A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

Exogenous Lipoid Pneumonia Mimicking Multifocal Bronchogenic Carcinoma

MET-Mutated NSCLC with Major Response to Crizotinib

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD

Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,

KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma Taylor M.

NA Journal of Thoracic Oncology

Electronic Updates for JTO Readers

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer Hiroyasu Kaneda, MD, PhD, Isamu.

Numb Chin Syndrome: An Ominous Sign of Lung Cancer

Pulmonary botryomycosis: A difficult diagnosis in the preoperative patient Russell Hodgson, MBBS, Shane A. Blackmore, MBBS, C. Peter Clarke, FRACS The.

Hibernoma: 18F FDG PET/CT Imaging

Frank Detterbeck, MD Journal of Thoracic Oncology

A Severe Photosensitivity Dermatitis Caused by Crizotinib

A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib Parneet K. Cheema, MD, MBiotech, FRCPC Journal.

Intramedullary Reactive Fibrosis as Mimic of Prostate Cancer Bone Metastasis on 11C- Choline Positron Emission and Computed Tomography Tyler Trump, BS,

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

A New KIT Gene Mutation in Thymic Cancer and a Promising Response to Imatinib Sung Hee Lim, MD, Ji-Yun Lee, MD, Jong-Mu Sun, MD, PhD, Kyoung-Mee Kim,

Metastasectomy in a lung graft using high-flow venovenous extracorporeal lung support in a patient after single lung transplantation Bassam Redwan, MD,

Solitary Choriocarcinoma in the Lung

Aya Fukuizumi, MD Journal of Thoracic Oncology

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller Yangki Seok,

A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib Oliver Gautschi, MD, Chantal Pauli, MD, Klaus Strobel, MD, Astrid Hirschmann,

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Four-Year Complete Remission in a Patient with Metastatic Epidermal Growth Factor Receptor–Mutated Lung Cancer Treated with Two Cycles of Erlotinib Brendan.

Rapid Response to Trastuzumab Emtansine in a Patient with HER2-Driven Lung Cancer Daniela Weiler, MD, Joachim Diebold, MD, Klaus Strobel, MD, Stefan.

PET/CT Findings for Bone Marrow Carcinosis Because of Lung Adenocarcinoma Keisuke Watanabe, MD, Masaharu Shinkai, MD, PhD, Kenjiro Nagai, MD, Nobuhiro.

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.

Identification of a subcentimeter pulmonary adenocarcinoma using intraoperative near- infrared imaging during video-assisted thoracoscopic surgery Jane.

A Rare Central Thoracic Tumor

Combination Treatment Using an EGFR Tyrosine Kinase Inhibitor plus Platinum-Based Chemotherapy for a Patient with Transformed Small Cell Carcinoma and.

Pulmonary Metastases from Cervical Adenocarcinoma Regress to a ‘Hole’ Lot of Nothing Michael Guandalini, MBBS (Hons), BPhty, Karin Steinke, MD, MS, PD,

A Case of Nontuberculous Mycobacteria Highly Suspected as Lung Cancer Invading the Aortic Arch Tadashi Umehara, MD, Masaya Aoki, MD, PhD, Aya Harada,

Mirror Mirror on the Wall, Who Is the Fairest of Them All

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer Allison Ackerman, MD, Michael A. Goldstein,

The Number of Pulmonary Metastases: Influence on Practice and Outcome

Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy Yelena.

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

Matthew Reichert, MD, Eric S. Bensadoun, MD

Nicholas W. Choong, MD, Robert S. Hellman, MD

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Pulmonary Atelectasis after Stereotactic Ablative Radiotherapy for a Central Lung Tumor Sashendra Senthi, MBChB, FRANZCR, Eric F Ullmann, MD, Suresh.

Marianna Koczywas, MD, Mihaela C. Cristea, MD

European Lung Cancer Conference (ELCC) 2016 Organisation

Metastatic Lung Cancer to the Pancreas

Resection of a Solitary Pulmonary Metastasis from Prostatic Adenocarcinoma Misdiagnosed as a Bronchocele: Usefulness of 18F-Choline and 18F-FDG PET/CT

Successful AZD9291 Therapy Based on Circulating T790M

Cristiano Rampinelli, MD, Vittoria Vecchi, MD, Massimo Bellomi, MD

Textiloma on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Wolf in a Sheep's Clothing? David Petermann, MD, Michel Christodoulou,

EBUS-TBNA for the Clarification of PET Positive Intra-Thoracic Lymph Nodes—an International Multi-Centre Experience Robert C. Rintoul, FRCP, PhD, Kurt.

Journal of Thoracic Oncology

IASLC 6th Latin American Conference on Lung Cancer

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Popcorn in the Lung Journal of Thoracic Oncology

Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy Matthew S. Block, MD, PhD, Robert Vassallo,

Super Scan Using Positron Emission Tomography in Lung Cancer Patients

Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT Shuichi.

Presentation transcript:

Beware of the “Bronchocele,” Particularly in Patients with a History or Risk Factors for a Mucinous Carcinoma: A Response to the Article “Resection of a Solitary Pulmonary Metastasis from Prostatic Adenocarcinoma Misdiagnosed as a Bronchocele: Usefulness of 18F-Choline and 18F-FDG PET/CT” by Calais et al. Haval Balata, MBChB, MRCP (UK) Journal of Thoracic Oncology Volume 10, Issue 6, Pages e47-e48 (June 2015) DOI: 10.1097/JTO.0000000000000512 Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Computed tomography of the thorax demonstrating an intraluminal, elongated opacity in the lateral segment of the right middle lobe. Journal of Thoracic Oncology 2015 10, e47-e48DOI: (10.1097/JTO.0000000000000512) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 18-F-Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography demonstrating no FDG uptake within the right middle lobe lesion. Journal of Thoracic Oncology 2015 10, e47-e48DOI: (10.1097/JTO.0000000000000512) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions